Literature DB >> 29417469

Association between systemic leptin and neurotensin concentration in adult individuals with and without type 2 diabetes mellitus.

I Barchetta1, G Ciccarelli1, F A Cimini1, V Ceccarelli1, M Orho-Melander2, O Melander2, M G Cavallo3.   

Abstract

PURPOSE: Leptin is an adipokine which regulates appetite and energy balance through a mechanism partially mediated by neurotensin (NT) in central nervous system. Besides acting as a neurotransmitter, NT is expressed in human intestine where it promotes fat absorption and its circulating levels associate with obesity, type 2 diabetes mellitus (T2DM) and cardiovascular disease. Whether a relation exists between circulating leptin and NT levels has not been investigated yet. The aim of this study was to test the hypothesis of an association between plasma leptin and NT concentration in adults with or without T2DM.
METHODS: We recruited a population of 72 subjects (M/F: 39/33; age: 49.5 ± 10.6 years; BMI: 26.5 ± 4.7 kg/m2) including individuals with T2DM (n = 32) referring to our Diabetes Outpatient Clinics, Sapienza University of Rome, and healthy controls. Study participants underwent metabolic characterization; plasma leptin was measured by MILLIPLEX, Luminex, and proneurotensin (proNT), a stable precursor of NT, by chemiluminometric sandwich immunoassay.
RESULTS: Circulating median (25°-75°) leptin levels were 2.75 (1.27-4.93) ng/mL and did not differ between T2DM and non-diabetic subjects. Leptin concentration directly correlated with proNT (r = 0.41; p = 0.015); higher leptin levels were also associated with age, male gender, obesity, higher HOMA-IR, systolic blood pressure and C-reactive protein. Belonging to the highest pro-NT quartile correlated with greater leptin levels independent of age, gender and other confounders (r2 = 0.82, p = 0.02).
CONCLUSIONS: Circulating leptin is associated with higher proNT levels independent of diabetes, obesity and metabolic syndrome components; besides its effects on central leptin signaling, NT may influence energy balance by modulating circulating leptin concentration likely through a mechanism involving gut fat absorption.

Entities:  

Keywords:  Fatty acids; Intestine; Leptin; Neurotensin; Type 2 diabetes mellitus

Mesh:

Substances:

Year:  2018        PMID: 29417469     DOI: 10.1007/s40618-018-0845-9

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  22 in total

1.  Presynaptic Regulation of Leptin in a Defined Lateral Hypothalamus-Ventral Tegmental Area Neurocircuitry Depends on Energy State.

Authors:  Jing-Jing Liu; Nicholas T Bello; Zhiping P Pang
Journal:  J Neurosci       Date:  2017-10-31       Impact factor: 6.167

2.  Leptin acts via lateral hypothalamic area neurotensin neurons to inhibit orexin neurons by multiple GABA-independent mechanisms.

Authors:  Paulette B Goforth; Gina M Leinninger; Christa M Patterson; Leslie S Satin; Martin G Myers
Journal:  J Neurosci       Date:  2014-08-20       Impact factor: 6.167

Review 3.  CNS Targets of Adipokines.

Authors:  Craig Beall; Lydia Hanna; Kate L J Ellacott
Journal:  Compr Physiol       Date:  2017-09-12       Impact factor: 9.090

4.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

Authors:  M Matsuda; R A DeFronzo
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

5.  Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer, and mortality.

Authors:  Olle Melander; Alan S Maisel; Peter Almgren; Jonas Manjer; Mattias Belting; Bo Hedblad; Gunnar Engström; Ute Kilger; Peter Nilsson; Andreas Bergmann; Marju Orho-Melander
Journal:  JAMA       Date:  2012-10-10       Impact factor: 56.272

6.  Role of leptin in the regulation of glucagon-like peptide-1 secretion.

Authors:  Younes Anini; Patricia L Brubaker
Journal:  Diabetes       Date:  2003-02       Impact factor: 9.461

7.  Regulation of fat-stimulated neurotensin secretion in healthy subjects.

Authors:  Juergen Drewe; Svetlana Mihailovic; Massimo D'Amato; Christoph Beglinger
Journal:  J Clin Endocrinol Metab       Date:  2008-02-26       Impact factor: 5.958

Review 8.  Structure, production and signaling of leptin.

Authors:  Heike Münzberg; Christopher D Morrison
Journal:  Metabolism       Date:  2014-09-28       Impact factor: 8.694

9.  Predictors of body composition and body energy changes in response to chronic overfeeding.

Authors:  C Bouchard; A Tchernof; A Tremblay
Journal:  Int J Obes (Lond)       Date:  2013-05-20       Impact factor: 5.095

10.  An obligatory role for neurotensin in high-fat-diet-induced obesity.

Authors:  Jing Li; Jun Song; Yekaterina Y Zaytseva; Yajuan Liu; Piotr Rychahou; Kai Jiang; Marlene E Starr; Ji Tae Kim; Jennifer W Harris; Frederique B Yiannikouris; Wendy S Katz; Peter M Nilsson; Marju Orho-Melander; Jing Chen; Haining Zhu; Timothy Fahrenholz; Richard M Higashi; Tianyan Gao; Andrew J Morris; Lisa A Cassis; Teresa W-M Fan; Heidi L Weiss; Paul R Dobner; Olle Melander; Jianhang Jia; B Mark Evers
Journal:  Nature       Date:  2016-05-11       Impact factor: 49.962

View more
  7 in total

Review 1.  Sick fat: the good and the bad of old and new circulating markers of adipose tissue inflammation.

Authors:  I Barchetta; F A Cimini; G Ciccarelli; M G Baroni; M G Cavallo
Journal:  J Endocrinol Invest       Date:  2019-05-09       Impact factor: 4.256

Review 2.  The Role of Central Neurotensin in Regulating Feeding and Body Weight.

Authors:  Jariel Ramirez-Virella; Gina M Leinninger
Journal:  Endocrinology       Date:  2021-05-01       Impact factor: 4.736

3.  Sex-Dependent Dyslipidemia and Neuro-Humoral Alterations Leading to Further Cardiovascular Risk in Juvenile Obesity.

Authors:  Estefania Simoes; Joanna Correia-Lima; Elie Leal de Barros Calfat; Thais Zélia Dos Santos Otani; Daniel Augusto Correa Vasques; Victor Henrique Oyamada Otani; Pamela Bertolazzi; Cristiane Kochi; Marilia Seelaender; Ricardo Riyoiti Uchida
Journal:  Front Nutr       Date:  2021-02-12

4.  High pro-neurotensin levels in individuals with type 1 diabetes associate with the development of cardiovascular risk factors at follow-up.

Authors:  Flavia Agata Cimini; Ilaria Barchetta; Laura Bertoccini; Valentina Ceccarelli; Marco Giorgio Baroni; Olle Melander; Maria Gisella Cavallo
Journal:  Acta Diabetol       Date:  2021-08-29       Impact factor: 4.280

Review 5.  New Insights in the Control of Fat Homeostasis: The Role of Neurotensin.

Authors:  Ilaria Barchetta; Marco Giorgio Baroni; Olle Melander; Maria Gisella Cavallo
Journal:  Int J Mol Sci       Date:  2022-02-17       Impact factor: 6.208

6.  Neurotensin Is a Lipid-Induced Gastrointestinal Peptide Associated with Visceral Adipose Tissue Inflammation in Obesity.

Authors:  Ilaria Barchetta; Flavia Agata Cimini; Danila Capoccia; Laura Bertoccini; Valentina Ceccarelli; Caterina Chiappetta; Frida Leonetti; Claudio Di Cristofano; Gianfranco Silecchia; Marju Orho-Melander; Olle Melander; Maria Gisella Cavallo
Journal:  Nutrients       Date:  2018-04-23       Impact factor: 5.717

Review 7.  Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1.

Authors:  Silvano Paternoster; Marco Falasca
Journal:  Front Endocrinol (Lausanne)       Date:  2018-10-11       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.